Different substituted coumarins have been synthesized and have shown activity as MAO-B inhibitors 10-15 and other coumarin derivatives have presented neuroprotective effects 16,17, which is important considering that currently it is expected that therapeutic alternatives control Parkinson’s disease symptoms and offer an approach to slow or stop the progression of neurodegeneration .18 The gene discussed is MAOB; the disease is Parkinson disease.